Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.06 USD | -5.36% | +17.80% | -23.19% |
May. 09 | Transcript : Bluebird bio, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 06 | Bluebird Bio, Inc. Announces Completion of First Cell Collection for LYFGENIA Gene Therapy | CI |
Financials (USD)
Sales 2023 * | 37.38M | Sales 2024 * | 124M | Capitalization | 204M |
---|---|---|---|---|---|
Net income 2023 * | -199M | Net income 2024 * | -238M | EV / Sales 2023 * | -0.98 x |
Net cash position 2023 * | 241M | Net cash position 2024 * | 106M | EV / Sales 2024 * | 0.8 x |
P/E ratio 2023 * |
-0.64
x | P/E ratio 2024 * |
-0.68
x | Employees | 323 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 99.62% |
Latest transcript on bluebird bio, Inc.
1 day | -5.36% | ||
1 week | +17.80% | ||
Current month | +19.49% | ||
1 month | -8.62% | ||
3 months | +2.91% | ||
6 months | -64.43% | ||
Current year | -23.19% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Obenshain
CEO | Chief Executive Officer | 51 | 15-12-31 |
Director of Finance/CFO | 51 | 22-11-06 | |
Melissa Bonner
CTO | Chief Tech/Sci/R&D Officer | - | 21-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Vachon
CHM | Chairman | 65 | 14-07-15 |
Nick Leschly
BRD | Director/Board Member | 51 | 10-02-28 |
Richard Paulson
BRD | Director/Board Member | 56 | 23-04-02 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.47% | 0 M€ | -4.02% | ||
0.11% | 0 M€ | +2.72% | - | |
0.10% | 12 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 1.06 | -5.36% | 6,870,207 |
24-05-09 | 1.12 | +14.92% | 11,517,964 |
24-05-08 | 0.9746 | -3.50% | 7,679,327 |
24-05-07 | 1.01 | +1.00% | 3,550,756 |
24-05-06 | 1 | +11.14% | 20,043,956 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.19% | 204M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- BLUE Stock